LIPOPOLYSACCHARIDE FROM BRUCELLA-ABORTUS BEHAVES AS A T-CELL-INDEPENDENT TYPE-1 CARRIER IN MURINE ANTIGEN-SPECIFIC ANTIBODY-RESPONSES

被引:24
作者
BETTS, M
BEINING, P
BRUNSWICK, M
INMAN, J
ANGUS, RD
HOFFMAN, T
GOLDING, B
机构
[1] US FDA,CTR BIOL EVALUAT & RES,DIV HEMATOL,CELL BIOL LAB,BETHESDA,MD 20892
[2] NIAID,IMMUNOL LAB,BETHESDA,MD 20892
[3] USDA,NATL VET SERV LABS,SCI & TECHNOL ANIM & PLANT HLTH INSPECT SERV,AMES,IA 50010
关键词
D O I
10.1128/IAI.61.5.1722-1729.1993
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to determine the carrier nature of lipopolysaccharide from Brucella abortus (LPS-BA) in evoking humoral responses, normal and immunodeficient mice were immunized with trinitrophenyl (TNP)-conjugated LPS-BA (TNP-LPS-BA) and the responses were compared with those to known T-dependent and T-independent antigens. TNP-LPS-BA, like T-independent type 1 (TI-1) antigens such as TNP-BA and TNP-LPS from Escherichia coli (TNP-LPS-EC), generated anti-TNP responses in BALB/c, athymic BALB/c nu/nu, and CBA/N mice. In contrast, N-2,4-dinitrophenyl-beta-alanylglycylglycyl-substituted keyhole limpet hemocyanin, a typical T-dependent antigen, was not immunogenic in athymic mice, and TNP-Ficoll (T-independent type 2) was ineffective in eliciting humoral responses in CBA/N mice. These results indicate that LPS from B. abortus acts as a TI-1 carrier in generating antibody responses. In C3H/HeJ mice, TNP-LPS-BA generated higher-titer immunoglobulin G1 (IgG1), IgG2a, and IgG2b anti-TNP antibodies than TNP-LPS-EC. Compared with those from BALB/c mice, pure resting B cells isolated from C3H/Hej mice exhibited a 30-fold lower proliferative response to LPS-EC, whereas the LPS-BA response was reduced to a lesser extent (5-fold). This suggests that the disparity observed in antibody titers was due to different abilities of LPS from B. abortus and E. coli to stimulate C3H/HeJ B cells. The ability of LPS from B. abortus to act as a carrier in generating humoral immune responses indicates that LPS-BA can be substituted for whole B. abortus organisms in vaccine development.
引用
收藏
页码:1722 / 1729
页数:8
相关论文
共 33 条
[1]   BRUCELLA-ABORTUS STIMULATES HUMAN T-CELLS FROM UNINFECTED AND HIV-INFECTED INDIVIDUALS TO SECRETE IFN-GAMMA - IMPLICATIONS FOR USE OF BRUCELLA-ABORTUS AS A CARRIER IN DEVELOPMENT OF HUMAN VACCINES [J].
BLAY, R ;
HERNANDEZ, D ;
BETTS, M ;
CLERICI, M ;
LUCEY, DR ;
HENDRIX, C ;
HOFFMAN, T ;
GOLDING, B .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (04) :479-486
[2]  
BRUNSWICK M, 1988, J IMMUNOL, V140, P3364
[3]  
FINKELMAN FD, 1988, J IMMUNOL, V140, P1022
[4]  
GIRI JG, 1984, J IMMUNOL, V132, P223
[5]  
GOLDING B, 1986, J IMMUNOL, V137, P103
[6]  
GOLDING B, 1981, J IMMUNOL, V127, P220
[7]  
GOLDING B, 1984, J IMMUNOL, V136, P2966
[8]  
GOLDING B, 1991, AIDS RES HUM RETROV, V7, P471
[9]  
GOLDING B, 1990, TOPICS VACCINE ADJUV, P25
[10]   LIPOPOLYSACCHARIDE (LPS) FROM BRUCELLA-ABORTUS IS LESS TOXIC THAN THAT FROM ESCHERICHIA-COLI, SUGGESTING THE POSSIBLE USE OF B-ABORTUS OR LPS FROM B-ABORTUS AS A CARRIER IN VACCINES [J].
GOLDSTEIN, J ;
HOFFMAN, T ;
FRASCH, C ;
LIZZIO, EF ;
BEINING, PR ;
HOCHSTEIN, D ;
LEE, YL ;
ANGUS, RD ;
GOLDING, B .
INFECTION AND IMMUNITY, 1992, 60 (04) :1385-1389